SCHEMBL22845223

SCHEMBL22845223

c1ccc(-c2ccc3c(c2)oc2cccc(-c4cccc(-c5ccc(-c6nc(-c7ccccc7)nc(-n7c8ccccc8c8ccccc87)n6)cc5)c4)c23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.34
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
BACE1 P56817 1/20 0.32
PRKDC P78527 4/20 0.32
ATM Q13315 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24855980 1.00 HCRTR1 (0.34) HCRTR1PLA2G2APLA2G4ABACE1PRKDC
SCHEMBL22352160 1.00 HCRTR1 (0.34) HCRTR1PLA2G2APLA2G4ABACE1PRKDC
SCHEMBL24855976 1.00 HCRTR1 (0.34) HCRTR1PLA2G2APLA2G4ABACE1PRKDC
SCHEMBL24855961 0.99 HCRTR1 (0.34) HCRTR1PLA2G2APLA2G4ABACE1PRKDC
SCHEMBL24855837 0.98 HCRTR1 (0.33) HCRTR1PLA2G2APLA2G4ABACE1PRKDC
SCHEMBL22845316 0.98 HCRTR1 (0.34) HCRTR1PLA2G2APLA2G4ABACE1PRKDC
SCHEMBL24856138 0.97 HCRTR1 (0.32) HCRTR1PLA2G2APLA2G4ABACE1PRKDC
SCHEMBL22737974 0.97 HCRTR1 (0.35) HCRTR1PLA2G2APLA2G4ABACE1PRKDC
SCHEMBL24882763 0.97 HCRTR1 (0.33) HCRTR1PLA2G2APLA2G4ABACE1PRKDC
SCHEMBL22737569 0.97 HCRTR1 (0.35) HCRTR1PLA2G2APLA2G4ABACE1PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200407348-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2020-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200407348-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 HCRTR1 166/4885PLA2G2A 3432/4885PLA2G4A 3735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.